Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

Objective To assess the benefits and risks of short term (<12 months) or extended (>12 months) dual antiplatelet therapy (DAPT) versus standard 12 month therapy, following percutaneous coronary intervention with drug eluting stents. Design Meta-analysis of randomised controlled trials. Data so...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarese, Eliano Pio, Andreotti, Felicita, Schulze, Volker, Kołodziejczak, Michalina, Buffon, Antonino, Brouwer, Marc, Costa, Francesco, Kowalewski, Mariusz, Parati, Gianfranco, Lip, Gregory Y H, Kelm, Malte, Valgimigli, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410620/
https://www.ncbi.nlm.nih.gov/pubmed/25883067
http://dx.doi.org/10.1136/bmj.h1618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410620/
https://www.ncbi.nlm.nih.gov/pubmed/25883067
http://dx.doi.org/10.1136/bmj.h1618

Ejemplares similares